|
Most Generic User Fee Rates Coming by Oct. 31, ANDA Filers to Pay About $50K
Generic-drug makers, including those with backlogged ANDAs and companies submitting prior approval supplements (PASs) and drug master files (DMFs), will know by the end of October how much user fee money they’ll have to dole out to the FDA in fiscal 2013.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Related Articles
FDA Questions Reckitt’s Motives in Petition Denial, OKs Suboxone ANDAsFDA Questions Reckitt Benckiser’s Motives in Petition Denial, OKs Two Suboxone GenericsFDA: More Work May Be Needed to Discourage Anticompetitive PetitionsFDA Sets Higher Than Expected Fiscal 2013 Generic Facility Fees, Payment Due March 4
|
Subscribe
Archives